You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diet, nutrition and obesity

Setmelanotide for treating obesity caused by LEPR or POMC deficiency

  • Highly specialised technologies guidance
  • Reference number: HST21
  • Published:  06 July 2022
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Information about setmelanotide
  • 3 Committee discussion
  • 4 Implementation
  • 5 Evaluation committee members and NICE project team
  • Update information

Update information

Minor changes since publication

March 2025: Links were updated following publication of NICE's guideline on overweight and obesity management.

ISBN: 978-1-4731-4614-3


Previous page 5 Evaluation committee members and NICE project team
Back to top